Romero P - Search Results

1

TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer.

Salaun B, Zitvogel L, Asselin-Paturel C, Morel Y, Chemin K, Dubois C, Massacrier C, Conforti R, Chenard MP, Sabourin JC, Goubar A, Lebecque S, Pierres M, Rimoldi D, Romero P, Andre F. Salaun B, et al. Among authors: romero p. Cancer Res. 2011 Mar 1;71(5):1607-14. doi: 10.1158/0008-5472.CAN-10-3490. Epub 2011 Feb 22. Cancer Res. 2011. PMID: 21343393

2

The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas.

Rimoldi D, Romero P, Carrel S. Rimoldi D, et al. Among authors: romero p. Int J Cancer. 1993 May 28;54(3):527-8. doi: 10.1002/ijc.2910540329. Int J Cancer. 1993. PMID: 8509230 No abstract available.

3

HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.

Luescher IF, Romero P, Kuznetsov D, Rimoldi D, Coulie P, Cerottini JC, Jongeneel CV. Luescher IF, et al. Among authors: romero p. J Biol Chem. 1996 May 24;271(21):12463-71. doi: 10.1074/jbc.271.21.12463. J Biol Chem. 1996. PMID: 8647853 Free article.

4

Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.

Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P. Valmori D, et al. Among authors: romero p. Cancer Res. 1997 Feb 15;57(4):735-41. Cancer Res. 1997. PMID: 9044853

5

Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen.

Reed DS, Romero P, Rimoldi D, Cerottini JC, Schaack J, Jongeneel CV. Reed DS, et al. Among authors: romero p. Int J Cancer. 1997 Sep 17;72(6):1045-55. doi: 10.1002/(sici)1097-0215(19970917)72:6<1045::aid-ijc20>3.0.co;2-2. Int J Cancer. 1997. PMID: 9378539

6

Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.

Waanders GA, Rimoldi D, Liénard D, Carrel S, Lejeune F, Dietrich PY, Cerottini JC, Romero P. Waanders GA, et al. Among authors: romero p. Clin Cancer Res. 1997 May;3(5):685-96. Clin Cancer Res. 1997. PMID: 9815737

7

Circulating Melan-A/Mart-1 specific cytolytic T lymphocyte precursors in HLA-A2+ melanoma patients have a memory phenotype.

D'Souza S, Rimoldi D, Líenard D, Lejeune F, Cerottini JC, Romero P. D'Souza S, et al. Among authors: romero p. Int J Cancer. 1998 Dec 9;78(6):699-706. doi: 10.1002/(sici)1097-0215(19981209)78:6<699::aid-ijc6>3.0.co;2-u. Int J Cancer. 1998. PMID: 9833762

8

Human tumor immunotherapy. New opportunities as well as new challenges.

Cerottini JC, Valmori D, Rimoldi D, Romero P. Cerottini JC, et al. Among authors: romero p. Adv Exp Med Biol. 1998;451:247-50. Adv Exp Med Biol. 1998. PMID: 10026881 No abstract available.

9

Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice.

Men Y, Miconnet I, Valmori D, Rimoldi D, Cerottini JC, Romero P. Men Y, et al. Among authors: romero p. J Immunol. 1999 Mar 15;162(6):3566-73. J Immunol. 1999. PMID: 10092815

10

An antigen-targeted approach to adoptive transfer therapy of cancer.

Valmori D, Pittet MJ, Rimoldi D, Liénard D, Dunbar R, Cerundolo V, Lejeune F, Cerottini JC, Romero P. Valmori D, et al. Among authors: romero p. Cancer Res. 1999 May 1;59(9):2167-73. Cancer Res. 1999. PMID: 10232604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,106 results

Search Page

Filters